Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2025

Apr 11, 2025

30718_dirs_2025-04-11_d41d4985-630f-4dee-b156-d239ca54e5e8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-07-01

Reporting Person: VESSEY RUPERT (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-07-01 Stock Options (Right to Buy) $209.26 A 588 Acquired 2029-06-30 Common Stock (588) Direct